Sangamo Therapeutics, Inc. entered into a securities purchase agreement for a registered direct offering of common stock and warrants, expected to raise approximately $24.0 million.
AI Assistant
SANGAMO THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.